Franck Chauvin

9.2k citations

167 papers · 6.8k indexed · 2 hit papers · h-index 36

Impact in

Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Oncology top 0.5%
- Viral-associated cancers and disorders
- Lung Cancer Research Studies

Papers in

Family Practice 7
Oncology 64
- Cancer survivorship and care 13
- Cancer Treatment and Pharmacology 12
- Global Cancer Incidence and Screening 10

Co-authors: Thierry Philip Pierre Biron Jean‐Yves Cahn Anton Hagenbeek Cesare Guglielmi Bertrand Coiffier Dominique Bron Hans van der Lelie
Journals: Journal of Clinical Oncology (9 papers)Annals of Oncology (9 papers)British Journal of Cancer (8 papers)European Journal of Cancer (5 papers)Blood (4 papers)
Partner nations: France United States Italy

In The Last Decade

Franck Chauvin

160 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma 1995 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1995 New England Journal of Medicine
1987 New England Journal of Medicine

Peers

Countries citing papers authored by Franck Chauvin

Since Specialization

Citations

This map shows the geographic impact of Franck Chauvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Chauvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Chauvin more than expected).

Fields of papers citing papers by Franck Chauvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Chauvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Chauvin. The network helps show where Franck Chauvin may publish in the future.

Co-authors

The 25 scholars most cited alongside Franck Chauvin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franck Chauvin Line = papers co-authored together Franck Chauvin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	New French guidelines to adapt the “Isolate/Detect/Trace” strategy for COVID‐19 adult peoples or contacts considering the exponential spread of Omicron variant Health Science Reports ·Didier Lepelletier, Christian Chidiac, Zeina Mansour, Franck Chauvin	2022	1
2	Management of patients with monkeypox virus infection and contacts in the community and in healthcare settings: a French position paper Clinical Microbiology and Infection ·Didier Lepelletier, Bruno Pozzetto, Franck Chauvin, Christian Chidiac	2022	6
3	The physical activity experience of prostate cancer patients: a multicentre peer motivation monitoring feasibility study. The Acti-Pair study Pilot and Feasibility Studies ·Amandine Baudot, Nathalie Barth, Claire Colas, Maël Garros, Arnauld Garcin, Mathieu Oriol, Frédéric Roche, Franck Chauvin, Nicolas Mottet, David Hupin, (unknown)	2022	3
4	Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version JMIR Research Protocols ·Elise Vérot, Wafa Bouleftour, Corinne Macron, Romain Rivoirard, Franck Chauvin	2020	2
5	Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients Cancer Chemotherapy and Pharmacology ·Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, Olivier Colomban, Jérôme Guitton, Vérane Schwiertz, Véronique Régnier Denois, Benoît You, Florence Ranchon, Raymonde Maraval-Gaget, Pascal Girard, Franck Chauvin, Gilles Freyer, Michel Tod, Émilie Hénin, V. Trillet-Lenoir	2018	15
6	Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review Critical Reviews in Oncology/Hematology ·Romain Rivoirard, Julien Langrand-Escure, Mathieu Oriol, Fabien Tinquaut, Franck Chauvin, C. Rancoule, Nicolas Magné, Aurélie Bourmaud	2018	1
7	Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach Patient Preference and Adherence ·Max-Adrien Garcia, J. Kalecinski, Mathieu Oriol, A Bonne, Mohamed Lofti, Sophie Espenel, Fabien Tinquaut, P. Fournel, Olivier Collard, Cécile Vassal, Romain Rivoirard, Véronique Régnier Denois, Franck Chauvin, Aurélie Bourmaud	2018	5
8	Moving towards shared decision making in the physician-patient encounter in France: State of the art and future prospects Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen ·Nora Moumjid, Julien Carretier, Giovanna Marsico, François Blot, Christine Durif‐Bruckert, Franck Chauvin	2017	12
9	Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials Gynecologic Oncology ·Fabien Tinquaut, Gilles Freyer, Franck Chauvin, N. F. C. Gane, Eric Pujade‐Lauraine, Claire Falandry	2016	25
10	HPV vaccination among French girls and women aged 14–23 years and the relationship with their mothers’ uptake of Pap smear screening: A study in general practice Vaccine ·D. Lutringer-Magnin, Claire Cropet, G. Barone, G. Canat, J. Kalecinski, Yann Léocmach, Philippe Vanhems, Franck Chauvin, Christine Lasset	2013	12
11	Chondroitin sulphate mediated fusion of brain: neural folds in rat embryons SPIRE - Sciences Po Institutional REpository ·Céline Chauleur, F. Collet, C. Furtos, A. Nourrissat, P Seffert, Franck Chauvin	2008	9
12	[Acromio-clavicular dislocations treated by synthetic coraco-clavicular ligamentoplasty]. Laurent Mathieu, Frédéric Rongièras, P Fascia, D. Ollat, Franck Chauvin, G. Versier	2007	5
13	Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy British Journal of Cancer ·(unknown), Isabelle Ray‐Coquard, Christophe Borg, T. Bachelot, Catherine Sebban, I Philip, Gilles Clapisson, Axel Le Cesne, Pierre Biron, Franck Chauvin, Jean‐Yves Blay	2003	85
14	Impact of greenhouse warming on the West African summer monsoon Climate Dynamics ·K. Maynard, Royer J.-F., Franck Chauvin	2002	40
15	Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials Annals of Oncology ·Thomas Bachelot, Isabelle Ray‐Coquard, G. Catimel, C Ardiet, Jean‐Paul Guastalla, A Dumortier, Franck Chauvin, Droz Jp, Thierry Philip, M. Clavel	2000	98
16	Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer Lung Cancer ·Pierre Jean Souquet, Franck Chauvin, J P Boissel, J. P. Bernard	1995	29
17	Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy Lung Cancer ·V. Trillet-Lenoir, F. Mornex, Franck Chauvin, P. Fournel, A Voloch, M. Pérol, E. Laennec, D Piperno, Jacques Boyer, Jean-Michel Ardiet, C. Carrié, X. Montbarbon, Isabelle Marquis, P. Romestaing, P. Méré, Jean-Noël Talabard, J L Chassard, Jean‐Pierre Gérard, Thierry Schmitt, Jean‐Claude Guérin	1993	6
18	Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group. PubMed ·Giorgio Dini, T Philip, Olivier Hartmann, Ross Pinkerton, Franck Chauvin, Alberto Garaventa, Edoardo Lanino, Sandro Dallorso	1989	14
19	Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients Cancer Treatment Reviews ·Thierry Philip, A. Mercatello, Sylvie Négrier, I Philip, Paul Rebattu, P. Kaemmerlin, M Gaspard, E. Tognier, Valérie Combaret, J.T. Bijmann, C.R. Franks, Franck Chauvin, J. F. Moskovtchenko, M Favrot, M. Clavel	1989	22
20	Stage IV neuroblastoma alive progression free 17 months post-BMT are not cured Bone Marrow Transplantation ·T Philip, Olivier Hartmann, Charles S. August, Guglielmo Dini, F. Beaujean, J M Zucker, Jean‐Louis Bernard, Alberto Garaventa, Christine Lasset, Franck Chauvin, Alida J. Evans	1988	1

About Franck Chauvin

Franck Chauvin is a scholar working on Family Practice, Oncology, Geriatrics and Gerontology, Chemical Health and Safety and Neurology, having authored 167 papers that have together received 6.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (15 papers), Cancer survivorship and care (13 papers), Cancer Treatment and Pharmacology (12 papers), Lymphoma Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (11 papers), Global Cancer Incidence and Screening (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Healthcare Systems and Practices (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.9k citations), Oncology (3.3k citations), Genetics (1.2k citations), Neurology (1.5k citations) and Hematology (892 citations). Franck Chauvin has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Thierry Philip, Pierre Biron, Jean‐Yves Cahn, Anton Hagenbeek, Cesare Guglielmi, Bertrand Coiffier, Dominique Bron, Hans van der Lelie, Pieter Sonneveld and F Mandelli. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact